Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Mayer

Showing results (981-990 of 997) with videos related to

Pageof 100
Sort By:
HIV Medicine|March 1, 2023
Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIVLydia N Drumright, Robin M Nance, Stephanie A Ruderman, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)Stephen R Walsh, Cynthia L Gay, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
The Journal of Clinical Investigation|February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adultsKristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Open Forum Infectious Diseases|October 23, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency VirusSamuel R Schnittman, Márton Kolossváry, Gabriele Beck-Engeser, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy IndividualsNathan B Erdmann, Wilton B Williams, Stephen R Walsh, et al.
International Journal of Cardiology|May 6, 2023
Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIVWon Jun Lee, Haoxiang Cheng, Bridget M Whitney, et al.
AIDS (London, England)|February 23, 2026
Routine collection of patient-reported outcomes in HIV clinics: lessons learned after more than 130,000 assessments have been completedHeidi M Crane, Mindy Dai, Rob Fredericksen, et al.
Pageof 100

Showing results (981-990 of 997) with videos related to

Sort By:
Pageof 100
HIV Medicine|March 1, 2023
Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIVLydia N Drumright, Robin M Nance, Stephanie A Ruderman, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)Stephen R Walsh, Cynthia L Gay, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
The Journal of Clinical Investigation|February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adultsKristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Open Forum Infectious Diseases|October 23, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency VirusSamuel R Schnittman, Márton Kolossváry, Gabriele Beck-Engeser, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy IndividualsNathan B Erdmann, Wilton B Williams, Stephen R Walsh, et al.
International Journal of Cardiology|May 6, 2023
Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIVWon Jun Lee, Haoxiang Cheng, Bridget M Whitney, et al.
AIDS (London, England)|February 23, 2026
Routine collection of patient-reported outcomes in HIV clinics: lessons learned after more than 130,000 assessments have been completedHeidi M Crane, Mindy Dai, Rob Fredericksen, et al.
Pageof 100